Issue 4, 2021

Targeted nanoscale therapeutics for myocardial infarction

Abstract

Nanoscale therapeutics have promise for the administration of therapeutic small molecules and biologics to the heart following myocardial infarction. Directed delivery to the infarcted region of the heart using minimally invasive routes is critical to this promise. In this review, we will discuss the advances and design considerations for two nanoscale therapeutics engineered to target the infarcted heart, nanoparticles and adeno-associated viruses.

Graphical abstract: Targeted nanoscale therapeutics for myocardial infarction

Article information

Article type
Review Article
Submitted
01 Oct 2020
Accepted
03 Dec 2020
First published
16 Dec 2020

Biomater. Sci., 2021,9, 1204-1216

Targeted nanoscale therapeutics for myocardial infarction

H. L. Sullivan, N. C. Gianneschi and K. L. Christman, Biomater. Sci., 2021, 9, 1204 DOI: 10.1039/D0BM01677B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements